Invesco Ltd.
NYSE:IVZAsset Management
-$0.41 today
- Market cap
- $12.59B
- Beta
- 1.59
- P/E (TTM)
- -53.4
- EPS (TTM)
- -$0.54
- Dividend yield
- 2.94%
Volume 5.54M
Average 5.41M
IVZ Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Invesco Ltd.NYSE: IVZ
Free Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Free cash flow grows, but more slowly than its trailing trend
Q2 FY2026 free cash flow of $748.4M rose 31.0% year over year, behind the +64.2% change in trailing-twelve-month free cash flow. Sequentially, it rose 277.2% from the prior quarter. Over 3 fiscal years it compounded at +41.3% a year.
Context
- Free cash flow amounted to 22.6% of revenue in FY2025, up 4.1 pp from a year earlier.
- Free cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +31.0% toward the trailing-twelve-month pace of +64.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 1.44B USD
- Year-over-year change
- +28.6%
- 4-year CAGR
- +10.4%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.44B | +28.6% |
| FY2024 | 2024-12-31 | 1.12B | -1.4% |
| FY2023 | 2023-12-31 | 1.14B | +122.7% |
| FY2022 | 2022-12-31 | 510.3M | -47.4% |
| FY2021 | 2021-12-31 | 969.3M | — |
Free Cash Flow vs competitors
How IVZ compares with its peers on the latest reported figures
- IVZ's LTM Jun 2026 free cash flow of $1.97B is the 4th largest of the 11 companies compared; the peer median is $740.23M.
- Its year-over-year change of +64.2% is the highest of 11, against a peer median of +3.9%.
- Free cash flow amounts to 28.5% of revenue for IVZ, versus a peer median of 30.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $8.06B | +20.4% | +24.5% | 40.7% | |
| LTM Jun 2026 | $4.85B | +12.8% | +13.2% | 30.9% | |
| LTM Jun 2026 | $2.18B | +51.8% | -11.3% | 28.7% | |
| LTM Jun 2026 | $1.97B | +64.2% | +41.3% | 28.5% | |
| LTM Sep 2026 | $1.17B | +26.2% | -1.2% | 44.9% | |
| LTM Sep 2026 | $790.3M | -13.3% | -4.6% | — | |
| LTM Sep 2026 | $690.15M | +7.6% | +6.0% | 27.2% | |
| LTM Jun 2026 | $313.89M | -15.7% | -1.0% | 91.4% | |
| LTM Sep 2026 | $219.49M | -23.2% | -16.4% | 17.4% | |
| LTM Mar 2026 | $19.94M | +0.2% | -29.7% | 20.0% | |
| LTM Mar 2026 | $10.42M | -17.2% | +16.5% | 31.6% | |
| Peer median (excluding IVZ) | $740.23M | +3.9% | -1.1% | 30.9% | |
Competitors are the stored peer set for IVZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.97B | 925.5M | (96.9M) | 752.4M | (174.8M) |
| Depreciation & Amortization | 205.3M | 195.3M | 182.8M | 179.6M | 155.9M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 140.1M | 106.2M | 114.6M | 104.6M | 80M |
| Change in Working Capital | (294.3M) | (371.5M) | (173M) | 146.2M | (216.4M) |
| Accounts Receivables | 5.58B | 912.8M | 448.7M | 319.7M | (5.6M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (5.88B) | (1.28B) | (621.7M) | (173.5M) | (210.8M) |
| Other Non-Cash Items | (942.4M) | (152.3M) | 1.27B | 7.2M | 1.68B |
| Operating Cash Flow | 1.08B | 703.2M | 1.3B | 1.19B | 1.53B |
| Capital Expenditures | (108.8M) | (192.9M) | (164.3M) | (69.1M) | (84.3M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 236.5M |
| Purchases of Investments | (6.19B) | (2.95B) | (3.26B) | (4.47B) | (5.36B) |
| Sales of Investments | 5.41B | 2.74B | 3.21B | 4.48B | 4.23B |
| Other Investing Activities | 44.9M | 32.6M | (26.8M) | 126.8M | (300K) |
| Investing Cash Flow | (847.9M) | (375.6M) | (244.3M) | 68.4M | (974.4M) |
| Debt Repayment | 914.6M | (575M) | 251.2M | (922.9M) | 2.28B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (60.9M) | (244.7M) | (187.5M) | (79.3M) | (1.86B) |
| Dividends Paid | (544.5M) | (571.6M) | (594.7M) | (608.3M) | (581.9M) |
| Other Financing Activities | (191.9M) | 424.4M | (54.4M) | (51.1M) | 20.6M |
| Financing Cash Flow | 117.3M | (966.9M) | (585.4M) | (1.66B) | (149.5M) |
| Effect of Forex Changes | (39.7M) | (73.7M) | 26.4M | (32.4M) | 82.4M |
| Net Change in Cash | 307.8M | (713M) | 497.5M | (435.6M) | 483.8M |
| Free Cash Flow | 969.3M | 510.3M | 1.14B | 1.12B | 1.44B |
Invesco Ltd.
NYSE:IVZ
Intrinsic Alpha fair value
Locked
Current Price
$28.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.